The Future of Biobanks: Regulation, ethics, investment and the humanization of drug discovery Published by Business Insights in March 2009
The Future of Biobanks: Regulation, ethics, investment and the humanization of drug discoveryReport OverviewBiobanks collect and store human biospecimens, playing a vital role in the development of novel drugs and diagnostics. In recent years, large population-based bio...(more)
The Scandinavian Pharmaceutical Market Outlook to 2013: Policy environment, market structure, pipeli Published by Business Insights in March 2009
The Scandinavian Pharma Market Outlook to 2013: Policy environment, market structure, pipeline analysis and growth opportunitiesThe Scandinavian healthcare system and pharmaceutical market is well regulated, with the state bearing responsibility for a large proportion o...(more)
The Top Ten Global In-Vitro Diagnostics Companies: Positioning, performance and SWOT analyses Published by Business Insights in March 2009
The Top 10 Global In-Vitro Diagnostics Companies: Positioning, performanceand SWOT analysesThe in-vitro diagnostics (IVD) market continues to grow at a steady pace, driven by new fields such as molecular diagnostics and a growing consumer awareness surrounding disease m...(more)
Key Trends in Offshoring Pharmaceutical R&D: Company strategies, emerging markets and impact on Published by Business Insights in March 2009
Key Trends in Offshoring Pharmaceutical R&D: Company strategies, emerging markets and impact on ROIsOffshoring and outsourcing have become an increasingly critical contributor to pharma and biotech R&D strategies in recent years. They enable companies to focus o...(more)
Evolving Trends in Biopharmaceutical Licensing: Deal assessments, drivers and resistors Published by Business Insights in March 2009
Evolving Trends in Biopharmaceutical Licensing: Deal assessments, drivers and resistorsLarge Pharma companies have become heavily dependant upon alliances and in-licensing to gain access to technologies/new molecular entities from Biopharma. This reliance has strengthen...(more)
Technology Transfer Strategies: Maximizing the returns from new technologies Published by Business Insights in February 2009
Technology Transfer StrategiesMaximizing returns from new technologiesReport OverviewTechnology transfer is a long-established part of early-stage research within the pharmaceutical and biotechnology industries. Although technology transfer offices have traditionally be...(more)
Technology Transfer Strategies: Maximizing the returns from new technologies Published by Business Insights in February 2009
Report Overview
Technology transfer is a long-established part of early-stage research within the pharmaceutical and biotechnology industries. Although technology transfer offices have traditionally been associated with inefficiency and a lack of commercial judgment, r...(more)
The Cardiovascular Market Outlook to 2013: Competitive landscape & global market analysis Published by Business Insights in January 2009
The cardiovascular therapy area spans a range of treatment classes including anti-hypertensives, anti-dyslipidemics, anti-thrombotics, hematological preparations and cardiac therapies. Each sub-therapy area is facing a different set of issues and challenges, such as the...(more)
Delivery Mechanisms for Large Molecule Drugs: Successes and failures of leading technologies Published by Business Insights in January 2009
Delivery Mechanisms for Large Molecule DrugsSuccesses and failures of leading technologies and key drivers for market success
Emerging drug delivery technologies aim to improve measures of safety, efficacy, convenience and compliance in both new and existing drug candi...(more)
Registered Office: 2a Altons House Office Park, Gatehouse Way, Aylesbury, HP19 3XU, UK
Registered in England and Wales No. 3240740 VAT No. GB 685 4343 10
CMSInfo (Chiltern Magazine Services Ltd.) is a company registered at Companies House in England and Wales (Company No. 3240740). CMSInfo is also registered in accordance with the Data Protection Act 1998 (registration number R0094104).
